Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	14.31	53.84	47.10
Graham Fair Price	-74.76	12.43	49.25
PEG	627.17	2.52	0.35
Price/Book	19.32	2.74	2.29
Price/Cash Flow	-22.15	-64.11	82.35
Prices/Earnings	1737.60	-268.41	14.61
Price/Sales	23.45	3.23	2.62
Price/FCF	-22.15	-64.11	82.35
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	23.07	0.07	0.06
Operating Margin	-51.07	0.03	0.06
ROA	-93.26	< 0.005	0.02
ROE	0.04	< 0.005	-93.51
ROIC	0.03	0.01	-58.72
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	-0.02	-131.17
Dividends QOQ	< 0.005	< 0.005	-95.69
EBIT QOQ	0.42	-0.53	25.80
EPS QOQ	0.42	-1.06	152.71
FCF QOQ	-0.18	-2.51	-1330.81
Revenue QOQ	-0.03	-0.05	-41.72
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	39.84	38.65	-2.97
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.17	0.17	-4.16
Quick Ratio	1.16	1.11	-4.22
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	52.39	51.90	-0.94
Cash	13.92	10.23	-26.54
Capex	-3.91	-2.49	36.35
Free Cash Flow	1.46	-2.22	51.82
Revenue	45.95	43.99	-4.26
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.26	1.23	-2.77
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.73	3.68	34.61
Naive Interpretation	Member

06 - Financial Health · Weak

Rating